The emerging therapy of the medication represents a exciting development in the care of type 2 diabetes. Unlike existing drugs, tirzepatide affects dual pathways – the GLP-1 hormone and the GIP hormone – providing https://tirzepatidepeptide629592.jaiblogs.com/69107893/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment